Mackenzie Financial
FBIO icon

Mackenzie Financial’s Fortress Biotech FBIO Stock Holding History

Mackenzie Financial’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.13M Sell
528,913
-26,763
-5% -$76.8K ﹤0.01% 1175
2026
Q2 		$1.7M Buy
+555,676
New +$1.43M ﹤0.01% 1087

Other funds holding FBIO

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Shikiar Asset Management
Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return
180 Wealth Advisors
180 Wealth Advisors Federal Way, Washington $1.04B AUM 41.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Choreo LLC
Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return

Mackenzie Financial's FBIO Position: Q3 2026 in Review

Mackenzie Financial reduced its Fortress Biotech (FBIO) stake by 4.8% in Q3 2026, selling an estimated $76.8K and leaving 528,913 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

Mackenzie Financial first reported a position in FBIO in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.7M in Q2 2026. 26 funds tracked by Wall St. Rank hold FBIO as of Q3 2026.

  • Mackenzie Financial held 528,913 shares of Fortress Biotech worth $1.13M as of Q3 2026.
  • Mackenzie Financial sold 26,763 Fortress Biotech shares in Q3 2026, an estimated $76.8K.
  • Fortress Biotech made up ﹤0.01% of Mackenzie Financial's portfolio in Q3 2026, its #1175 holding.
  • Mackenzie Financial first reported a position in Fortress Biotech in Q2 2026 and has held it in 2 quarters since.
  • Mackenzie Financial's Fortress Biotech position peaked at $1.7M in Q2 2026.
  • 26 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.